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Chronic wounds, such as venous ulcers, affect hundreds of thousands of patients each year. They represent a serious healthcare problem around theworld. Venous ulcers develop as a consequence of venous valvular incompetence causing venous reflux, obstruction and subsequently venous hypertension. Their chronicity, frequent relapses and associated complications heavily impact patient's quality of life and increase healthcare costs.
Venous ulcers are responsible for more than half of lower extremity ulcerations, with prevalence ranging from 0.06% to 2% [1] . A rough estimate shows that the prevalence of unhealed venous ulcers is about 0.3%, that is about 1 in 350 adults [2] , or approximately 400,000-600,000 cases in the United States [3] .
Treatment of these ulcers sometimes requires numerous hospitalizations and treatment modalities incorporating topical dressings, antibiotics, debridement, compression therapy and cellular therapy. After wound healing with non-operative methods the incidence rate of recurrent ulcerations after 3 and 5 years was
reported to be 37% and 48%, respectively [3] . The [4] , and in one retrospective cohort study the average total medical cost per patient was $9685 (median: $3036) [5] . Currently, only human skin equivalent is approved (for safety and efficacy) therapy in venous ulcers. [6] . [7] . Basal keratinocytes divide and as they start differentiating and leaving the basal compartment they undergo changes in gene expression and commit to terminal differentiation resulting in formation of enucleated corneocytes. Once the barrier is broken, keratinocytes become activated in response to epidermal injury and start to proliferate, migrate and express a specific subset of keratin proteins suprabasally, keratins 6, 16 and 17 [8] .
Lack of understanding the biology at a cellular and molecular level is a barrier to creating further effective treatments. Healthy epidermis provides a protective barrier that undergoes constant renewal. In this multi-layered, highly cellular tissue cellto-cell connection occurs via desmosomes, adherens junctions, gap and tight junctions (TJs). TJs control paracellular permeability and maintain cell polarity, thus maintaining barrier function
We [9, 10] . We [9] .These changes suggest inadequate execution of either of the two major processes important for epidermal maintenance and homeostasis: activation and differentiation. [11, 12] and wound healing of different tissues [13] [14] [15] [16] [17] [18] [10] . [3, 23] . (Fig. 4) [24, 25] . All three pocket proteins of the Rb family, Rb, p107 and p130 were found down-regulated in (Fig. 6B) . Up-regulation of DEFB4 has been shown to be associated with benign hyperplasia in skin [27] .
have shown previously that skin deriving from the nonhealing edge of chronic ulcers (e.g. venous, pressure and diabetic foot ulcers) exhibits distinct morphology. The epidermis becomes hyperproliferative, hyper-and parakeratotic with the presence of mitoticaly active cells in suprabasal layers
have also shown that activation of c-myc and nuclearization of ␤-catenin in the epidermis of patients with chronic wound play a role in inhibition of keratinocyte migration and contribute to impairment of healing in chronic wounds
To test if indeed these two processes are impaired in venous ulcers, we utilized large-scale microarray analyses and biopsies of non-healing edges of three patients suffering from venous ulcers. Microarray technology has brought the ability to simultaneously analyse the expression patterns of tens of thousands of genes and thereby identify groups of differentially regulated genes involved in pathogenesis of many different diseases. It has been used successfully in gene expression analyses of various tumours
Debridement techniques of venous ulcers
fw (5Ј-AAAGGACCCCACGAAGTGTT-3Ј) and rev primer (5Ј-TCAAGGGCATATCCTACAACAA-3Ј); DEFB4, fw (5Ј-GGTGGTATAGGC-GATCCTGTT-3Ј) and rev primer (5Ј-AGGGCAAAAGACTGGATGACA-3Ј); KLK6, fw (5Ј-CATGGCGGACCCCTGCGACAAGAC-3Ј) and rev primer (5Ј-TGGATCACAGCCCGGACAACAGAA-3Ј); MMP11 fw (5Ј-AGATCTAC T T C -T TCCGAGGC) and rev primer (5Ј-TTCCAGAGCCTTCACCTTCA-3Ј); CCL27 fw (5Ј-TCCTGAGCCCAGACCCTAC-3Ј) and rev primer (5Ј-CAGTTCCACCTG-GATGACCTT-3Ј); APOD fw (5Ј-AATCAAATCGAAGGTGAAGCCA) and rev primer (5Ј-ACGAGGGCATAGTTCTCATAGT-3Ј); S100A7 fw (5Ј-GGAGAA C T -T CCCCAACTTCC-3Ј) and rev primer (5Ј-ACATCGGCGAGGTAATTTGT-3Ј); BMP2 fw (5Ј-TCAAGCCAAACACAAACAGC-3Ј) and rev primer (5Ј-GTG-GCAGTAAAAGGCGTGAT-3Ј); BMP7 fw (5Ј-AGGCCTGTAAGAAGCACGAG-3Ј) and rev primer (5Ј-GGTGGCGTTCATGTAGGAGT-3Ј); K17 fw (5Ј-GGTGGG -T GGTGAGATCAATGT-3Ј) and rev (5Ј-CGCGGTTCAGTTCCTCTGTC). Statistical comparisons of expression levels were performed using Student's t-test.
Results
To determine genes that play a role in pathogenesis of venous ulcers we performed microarray analysis, utilizing biopsies from non-healing edges of venous ulcers from three patients with venous stasis ulcers and three healthy skin specimens. All three patients presented with an ulcer on a lower left leg, longer than an year in duration (Fig. 1). Proper diagnosis was made following previously published guidelines and protocols
Evaluation for ischaemia was performed either by non-invasive flow exams (ankle-brachial index of
Fig. 1 An image of a venous ulcer used in this study. The arrow is pointing to the location of a non-healing edge from which biopsy for microarray analysis was obtained.
Fig. 2 Gene tree showing different gene expression patterns between venous ulcers (left) and healthy skin (right
Chemokines which mediate T cell chemotaxis were found suppressed. The expression of cutaneous T-cell attracting chemokine (CCL27), was almost abolished (Fig. 6C) (Fig. 6C) , consistent with previously published data [28] .
In summary, microarray data show changes consistent with morphology, suggesting deregulation and incomplete activation of keratinocytes at the non-healing edge in epidermis of venous ulcers.
Keratinocyte differentiation: markers, cornified envelope and barrier formation
In intact skin, the major role of keratinocyte terminal differentiation is to form a physical barrier that acts as permeability barrier against water loss, foreign microbes and toxins. The cornified cell envelope and TJs [7] (Fig. 7) .
Interestingly, additional components of the cornified envelope, including involucrin (IVL) and small proline-rich proteins (SPRR1A, SPRR1B, SPRR2B, SPRR3) were up-regulated, whereas transglutaminase 1 (TGM1), an enzyme responsible for cross-linking SPRR's and IVL into the cornified envelope, was up-regulated. To confirm microarray data at the protein level, we used immunohistochemistry and stained patients' biopsy specimens with K10, IVL and FLG-specific antibodies. We found robust increase of IVL, whereas K10 and FLG were barely detected in specimens derived from venous ulcers © 2008 The Authors Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 5 K17 is up-regulated in non-healing edges of venous ulcers. (A) Real-time PCR confirms K17 up-regulation in ulcers. K17 expression was normalized to expression level of HPRT. (B) Immunofluorescence with K17-specific antibody shows induction of K17 in non-healing edge of venous ulcer.
Scale bar 50 m. (Fig. 7) . In addition, several other molecules that participate in epidermal differentiation were found to be regulated. S100A7, a member of human epidermal differentiation complex (EDC), S100A8, S100A9, S100A12 and kalikrein 6 (KLK6) were among the top up-regulated genes. We used realtime PCR to confirm these findings (Fig. 6D) 
(Fig. 8). Among newly identified potential markers of keratinocyte terminal differentiation [29], we found skin-derived protease inhibitor 3 (SKALP/PI3), oxysterol-binding protein-like 8 (OSBPL8), adducing 3 (ADD3), early growth response 3 (EGR3), inhibitor of DNA binding 4 (ID4), occluding (OCLN) and decayaccelerating factor for complement (DAF) down-regulated, whereas septin 8 (SEPT8), serine/threonine kinase 10 (STK10) and serine/cysteine proteinase inhibitor, clade B, member 3 (SER-PINB3) were up-regulated
. TJ in skin are complex structures localized in granular layer. These junctions are composed of transmembrane (claudin 1-20, ocludin) and plaque (symplekin (SYMPK) and ZO 1-3) proteins [30, 31]. We found that different structural components of TJs, such as TJ protein 3 (ZO3, TJP3), spectrin 1(SPTBN1), InaD-like protein (MUPP1, INADL), occludin (OCLN), claudin 5 (CLDN5), claudin 8 (CLDN8) down-regulated in the non-healing edge of venous ulcers. Interestingly, only SYMPK was found up-regulated. Formation of TJs in epidermis, during differentiation, is a precisely regulated spatiotemporal process. An important component of this regulation is polarity complex Par3, Par6, atypical PKC-iota (PARD)
and CDC42 [32] . We found that different components of polarity [7, 33] . Furthermore, up-regulation of phospholipase D2 (PLD2) but not phospholipase D1 (PLD1) was found. The activation of these regulators has been implicated in late keratinocyte differentiation [34] increased signal throughout the epidermis of venous ulcers while signal of DP was decreased thus confirming deregulation of desmosomal proteins (Fig. 9) . [40] [41] [42] [43] . Thus, their induction is consistent with prolonged inflammation found in chronic wounds [44, 45] .
Fig. 6 Real-time PCR confirmation of selected genes differentially expressed in healthy skin and venous ulcers. Quantitative real-time PCR for the expression of BMP2 and BMP7 (A), APOD and DEFB4 (B), CCL27 and MMP11 (C), S100A7 and KLK6 (D). Mean values of expression levels were represented after normalization to expression level of HPRT1. complex, PARD and CDC42 are down-regulated in chronic wounds when compared to healthy skin. Taken together, data obtained from microarray analysis indicate deregulation of early and late differentiation markers, aberrant cornified envelope assembly and deregulation of TJ molecules. This suggests a possible loss of barrier function in the epidermis of venous ulcers.
Keratinocyte differentiation: regulators
Microarray analyses revealed down-regulation of kuppel-like factor (KLF4), transcription factor, important for the establishment of skin barrier function as well as cross-linking of cornified envelope proteins
Discussion
In this paper we present comprehensive analyses of the pathogenesis of non-healing edges of venous ulcers using transcriptional
it has been shown that pro-inflmmatory signals, including tumour necrosis factor-␣ (TNF-␣), IL-1 and interferon-␥ (IFN-␥) induce expression of these genes
We have shown previously that non-healing edge keratinocytes are marked by induction of c-myc and nuclear presence of ␤-catenin, leading to increased proliferation and inhibition of migration [9] . [47] . SDF-1␣ from keratinocytes and myofibroblasts has been shown to participate in homing of endothelial progenitor cells to the wound site. The db/db mouse wound model exhibit decreased expression of SDF-1␣, suggesting possible decrease in diabetic foot ulcers [48, 49] . Interestingly, we found SDF1␣ up-regulated in venous ulcers.
Data collected in this study further expands and confirms previous findings. Promotion of G1/S and G2/M cell cycle transitions in venous ulcers environment and loss of cell cycle control coupled with c-myc induction and keratinocytes activation may lead to a hyperproliferative phenotype. However, further conformation would require evaluation at the protein level, including posttranslation modifications and phosphorylation in particular. On the other hand, the loss of cell cycle control is not complete and some factors, like cyclin D1 and EIF4E, usually overexpressed during tumourigenesis [46] were down-regulated in venous ulcers. MFNG expression is restricted to proliferative basal layer during embryonic epidermal stratification [36], and up-regulation of MFNG in non-healing edges coupled with the presence of mitotically active cells in suprabasal layers may suggest its possible role in the induction of keratinocyte proliferation. We found down-regulation of IL-6 expression in non-healing edges of venous ulcers, which is consistent with findings in IL-deficient mice (interleukin-6 knockout (IL-6KO)) that display delayed wound closure
This may indicate that changes in SDF-1␣ expression may be associated specifically with diabetes rather than with impaired healing in general.
Keratinocyte early differentiation markers K1/K10 were downregulated in our experiment, which is consistent with previous findings and further validates our microarray analyses [50] . Up-regulation of TGM1, an enzyme involved in the initial cross linking during cornification process along with IVL, which is a major early cross-linked component of cornified envelope as well as S100A7 and SPRR1A, SPRR1B, SPRR2B, SPRR3, indicates improper cornified envelope assembly [51] . FLG, one of the key proteins that facilitate terminal differentiation of the epidermis and formation of the skin barrier, was found down-regulated. It has been shown that once keratinocytes process pro-FLG into FLG they undergo specific changes that mark terminal differentiation [52] , and that perhaps this process demarcates the 'line of regenerative potency' among the population of differentiating keratinocytes [53] . Down [54] . Furthermore, the highest levels of PLD1 expression were found in the more differentiated layers of the epidermis, with negligible expression in basal keratinocytes [55] . Down [7, 33] [37] and, further, how to standardize the wound biopsy from patient to patient [10] 
